Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP312246.RAXFoBzQhe0lO4142FzFcPUeWjx6d2ByUDwoaX2HwTEeQ130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP312246.RAXFoBzQhe0lO4142FzFcPUeWjx6d2ByUDwoaX2HwTEeQ130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP312246.RAXFoBzQhe0lO4142FzFcPUeWjx6d2ByUDwoaX2HwTEeQ130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP312246.RAXFoBzQhe0lO4142FzFcPUeWjx6d2ByUDwoaX2HwTEeQ130_provenance.
- befree-20150227 importedOn "2015-02-27" NP312246.RAXFoBzQhe0lO4142FzFcPUeWjx6d2ByUDwoaX2HwTEeQ130_provenance.
- NP312246.RAXFoBzQhe0lO4142FzFcPUeWjx6d2ByUDwoaX2HwTEeQ130_assertion wasGeneratedBy ECO_0000203 NP312246.RAXFoBzQhe0lO4142FzFcPUeWjx6d2ByUDwoaX2HwTEeQ130_provenance.
- NP312246.RAXFoBzQhe0lO4142FzFcPUeWjx6d2ByUDwoaX2HwTEeQ130_assertion wasDerivedFrom befree-20150227 NP312246.RAXFoBzQhe0lO4142FzFcPUeWjx6d2ByUDwoaX2HwTEeQ130_provenance.
- NP312246.RAXFoBzQhe0lO4142FzFcPUeWjx6d2ByUDwoaX2HwTEeQ130_assertion SIO_000772 10436809 NP312246.RAXFoBzQhe0lO4142FzFcPUeWjx6d2ByUDwoaX2HwTEeQ130_provenance.
- NP312246.RAXFoBzQhe0lO4142FzFcPUeWjx6d2ByUDwoaX2HwTEeQ130_assertion evidence source_evidence_literature NP312246.RAXFoBzQhe0lO4142FzFcPUeWjx6d2ByUDwoaX2HwTEeQ130_provenance.
- NP312246.RAXFoBzQhe0lO4142FzFcPUeWjx6d2ByUDwoaX2HwTEeQ130_assertion description "[For biliopancreatic malignancy, following CEA as more historical and basic TM of gastrointestinal diseases, the mainstay marker is CA 19-9 as monosialo-ganglioside/glycolipid and sialyl derivative of lacto-N-fucopentaose II (sialyl-Lewis(a), hapten of human Lewis(a) bloodgroup determinant).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP312246.RAXFoBzQhe0lO4142FzFcPUeWjx6d2ByUDwoaX2HwTEeQ130_provenance.